Pulmonary resection and chemotherapy for metastatic alveolar soft-part sarcoma
โ Scribed by Edward S. Baum; Farouk Idriss; James B. Nachman; Larry Fickenscher
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 289 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Alveolar soft-part sarcoma (ASPS) is an unusual tumor of soft tissues; it has invariably ended in death from disseminated disease, and the lung has been the most common site of metastasis. We present a patient with ASPS with bilateral pulmonary tnetastases who achieved a complete response after bilateral thoracotomies with removal of all gross disease and after combination chemotherapy including vincristine, actinomycin D, cyclophosphamide, and doxorubicin. The patient has now been followed for five years since the appearance of the metastases and has been off therapy for the past 34 months. He shows no evidence of disease. We suggest that multiniodality therapy is a reasonable approach in patients with ASPS and pulmonary metastases and that such therapy has the potential for improving survival.
๐ SIMILAR VOLUMES
Metastasis to the breast is uncommon, with an incidence of 0.5-3%. Alveolar soft part sarcoma is rare, accounting for < 1 % of malignant soft tissue tumors, which are themselves unusual. Excluding contralateral breast and hematologic malignant disease, the primary lesion in most cases of metastasis
A cytogenetic study of an alveolar soft-part sarcoma, a rare tumor of probably myogenic origin, demonstrated a t(X;17)(p11; q25) as the sole chromosomal abnormality. Dual-and triple-color fluorescence in situ hybridization, performed on metaphase and interphase cells, confirmed the translocation bet